All In Biotech

Drug Trial Radar · NCT04143594

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

A Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhibitor GS-6207 in Combination With Other Antiretroviral Agents in People Living With HIV

Last checked: Nov 19, 2026Latest source record: Oct 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 183 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

183

Actual

Start

Nov 22, 2019

Primary completion

Oct 5, 2021

Study completion Sep 19, 2023

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
First posted
Oct 29, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the efficacy of lenacapavir (formerly GS-6207) containing regimens in people living with human immunodeficiency virus (HIV) (PLWH).

Conditions

  • HIV-1-infection

Interventions

  • Oral LenacapavirDrug

    Tablets administered without regard to food

  • F/TAFDrug

    Tablets administered without regard to food

  • Subcutaneous LenacapavirDrug

    Administered in the abdomen via subcutaneous injections

  • TAFDrug

    Tablets administered without regard to food

  • BICDrug

    Tablets administered without regard to food

  • B/F/TAFDrug

    Tablets administered without regard to food

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Human Immunodeficiency Virus-1 Ribonucleic Acid (HIV-1 RNA) < 50 Copies/mL at Week 54 as Determined by the United States Food and Drug Administration (US FDA)-Defined Snapshot AlgorithmTime frame: Week 54

Locations

53 sites in 3 countries. Site status is shown where the registry gives one.

  • Valleywise Community Health Center - McDowell

    Phoenix, Arizona

  • Pueblo Family Physicians

    Phoenix, Arizona

  • Ruane Clinical Research Group Inc

    Los Angeles, California

  • Mills Clinical Research at Men's Health Foundation

    Los Angeles, California

  • Eisenhower Health Center at Rimrock

    Palm Springs, California

  • University of Colorado, Denver, University of Colorado Hospital

    Aurora, Colorado

  • Denver Public Health

    Denver, Colorado

  • Yale University; School of Medicine

    New Haven, Connecticut

  • Georgetown University Hospital

    Washington D.C., District of Columbia

  • Whitman-Walker Institute, Inc.

    Washington D.C., District of Columbia

  • Washington Health Institute

    Washington D.C., District of Columbia

  • Midland Florida Clinical Research Center, LLC

    DeLand, Florida

  • Midway Immunology and Research Center

    Ft. Pierce, Florida

  • Floridian Clinical Research

    Hialeah, Florida

  • AHF-The Kinder Medical Group

    Miami, Florida

  • AIDS Healthcare Foundation - South Beach

    Miami Beach, Florida

  • Orlando Immunology Center

    Orlando, Florida

  • St. Joseph's Hospital Comprehensive Research Institute

    Tampa, Florida

  • Triple O Research Institute, P.A.

    West Palm Beach, Florida

  • Atlanta ID Group, PC

    Atlanta, Georgia

  • August University Medical Center

    Augusta, Georgia

  • Infectious Disease Specialists of Atlanta

    Decatur, Georgia

  • Mercer University, Department of Internal Medicine

    Macon, Georgia

  • Chatham County Health Department

    Savannah, Georgia

  • Howard Brown Health Center

    Chicago, Illinois

  • Northstar Healthcare

    Chicago, Illinois

  • Indiana University Infectious Diseases Research

    Indianapolis, Indiana

  • Be Well Medical Center

    Berkley, Michigan

  • St. John Newland Medical Associates

    Southfield, Michigan

  • KC CARE Health Center

    Kansas City, Missouri

  • AHF-Midtown

    New York, New York

  • Montefiore Medical Center

    The Bronx, New York

  • East Carolina University, The Brody School of Medicine

    Greenville, North Carolina

  • Rosedale Infectious Diseases

    Huntersville, North Carolina

  • University of Cincinnati

    Cincinnati, Ohio

  • Case Clinical Research Site/University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • The Ohio State University Medical Center

    Columbus, Ohio

  • Allegheny Health Network

    Pittsburgh, Pennsylvania

  • St. Jude Children's Research Hospital

    Memphis, Tennessee

  • Central Texas Clinical Research

    Austin, Texas

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.